Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1988 Mar;81(3):918-23.
doi: 10.1172/JCI113403.

Differential effects of the complement peptides, C5a and C5a des Arg on human basophil and lung mast cell histamine release

Affiliations

Differential effects of the complement peptides, C5a and C5a des Arg on human basophil and lung mast cell histamine release

E S Schulman et al. J Clin Invest. 1988 Mar.

Abstract

The ability of purified anaphylatoxins to induce human lung mast cell mediator release was investigated. In eight anti-IgE responsive (histamine release = 22 +/- 5%, mean +/- SEM) mast cell preparations of 1-96% purity, C5a and C5a des Arg (0.55 pg/ml to 55 micrograms/ml), failed to elicit or potentiate histamine release; lung fragments were similarly unresponsive. The related peptide C3a was also inactive. All anaphylatoxins failed to induce mast cell leukotriene C4 (LTC4) and prostaglandin D2 (PGD2) release. LTC4 release was also negligible from basophils where C5a was a potent histamine release stimulus. Supernatants from C5a-challenged mast cells remained fully active on basophils, excluding carboxypeptidase inactivation of C5a as an explanation for the lung mast cell results. In contrast to lung, skin mast cells were C5a-responsive (histamine release = 8 +/- 1%, at 55 micrograms/ml, n = 2). We conclude that C5a, though devoid of activity on the human lung mast cell, is a human basophil and skin mast cell secretagogue. These findings demonstrate significant organ-specific heterogeneity in mast cell responsiveness.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Exp Med. 1968 Feb 1;127(2):371-86 - PubMed
    1. J Immunol. 1980 Jun;124(6):2876-8 - PubMed
    1. J Clin Invest. 1982 Oct;70(4):747-51 - PubMed
    1. J Immunol. 1985 Jan;134(1):541-7 - PubMed
    1. Am Rev Respir Dis. 1975 Sep;112(3):423-36 - PubMed

Publication types